-
Development of an alpha6*-Selective Neuronal Nicotinic Receptor (NNR) Imaging Agent as a Parkinson's Disease Biomarker
… of PD, such as depression, cognitive deficits, abnormal REM sleep, and loss of olfaction. This knowledge would be …
-
MJFF Awards $710,000 to Advance Understanding of Parkinson's Disease Subtypes
June 6, 2007
… clinical visit; and factors (such as mood analysis, sleep, cognitive function and pain) that may contribute to …
-
Addex Therapeutics Awarded $1 MM Grant from The Michael J. Fox Foundation for Parkinson's Research
March 19, 2013
… movement), “on-time” (with or without dyskinesia) and sleep. The trial was supported by a grant from The Michael …
-
Ask the MD: Getting Back to Pre-COVID Life
May 29, 2020
… Routine is good — it can help you ease stress, optimize sleep, and build healthy habits and self-care into daily …
-
PPMI Needs People At Risk for Parkinson’s — Even if Not Diagnosed with PD
March 22, 2021
… Genetic mutations in LRRK2 and/or GBA Diagnosis of REM sleep behavior disorder , a known precursor to Parkinson’s …
-
Parkinson’s Disease Therapeutics Conference Showcases Progress Toward Better Treatments
… disease, such as cognitive decline, gait problems, REM sleep behavior disorder (RBD) and olfactory dysfunction. …